Cagrilintide Satifarm 20 mg SunSci Pharma

You can buy Cagrilintid 20 mg in a pen injector at a favourable price

The Sport Market online emporium proffers Cagrilintide 20 mg in a pen injector — a superior pharmaceutical preparation from the renowned pharmaceutical company SunSci Pharmaceutical. This innovative treatment is used to treat obesity and type 2 diabetes. Its use can be standalone or in conjunction with glucagon-like peptide-based drugs, including semaglutide, tirzepatide and retatrudite, to boost the impact.

Information about the effects of Cagrilintide on the body

Cagrilintide is a drug in the experimental stage of development. It is a long-acting version of a hormone called amylin, which is produced by the pancreas along with insulin. It works by activating amylin and calcitonin receptors (DACRA).

Satiety is promoted by amylin, gastric emptying is slowed by it, and appetite is reduced by it. However, the natural form of this hormone breaks down quickly, which limits its therapeutic use. Cagrilintide works for longer and is more stable because of its special molecular structure. The brain's satiety centres are affected by it, which results in appetite being modulated and digestion being slowed down.

The following conditions are treated with Cagrilintide 20 mg pens:

• The appetite regulator functions by moderating both physiological and psychological eating disorders.

• Combining this with diet and reasonable physical activity is necessary to improve glycaemic control in adults with type 1 and type 2 diabetes.

• The drug can reduce the risk of serious adverse cardiovascular events in adults with type 1 or type 2 diabetes mellitus and established cardiovascular disease.

• It is important to lose body weight and reduce fat deposits.

• The need to enhance the therapeutic effect of GIP and GPP-1 receptor agonists. Examples of these are semaglutide, mazduotide, tirzepatide and retatrutide. Lower doses of these drugs can be used concomitantly with Cagrilintide.

  
  

A multicentre study was conducted. It was a double-blind phase 2 study. It took place at 17 medical centres in the United States. A duration of 32 weeks was experienced. The study involved adult patients with type 2 diabetes and a BMI of 27 or higher. These patients were taking metformin, either with or without an SGLT2 inhibitor. The participants were divided into three groups, each of which received injections of either semaglutide, cagrilintide, or a combination of both. The subsequent findings were acquired:

The results of the study show that cagrilintide is effective in controlling weight and hyperglycaemia. It is also highly effective when used alone. Combined with other treatments, it has a synergistic effect.

Consequently:

• Cagrilintide 20 mg pen can be recommended primarily for overweight individuals. It is recommended for individuals without concomitant diseases. These are diseases associated with impaired sugar metabolism.

• The drug is prescribed to patients with type 2 diabetes before they start therapy with GLP-1/GIP-GLP-1 receptor agonists. These drugs are based on the active substances semaglutide, mazduotide, tirzepatide and retatrutide. Moreover, it may be employed concomitantly with other pharmaceuticals to augment appetite control.

• Doctors can use Cagrilintide to treat patients with type 1 diabetes who cannot use GLP-1/GIP-GLP-1 agonists.

Appetite suppression, nausea, constipation or diarrhoea, a significant slowing of digestion and a feeling of fullness in the stomach are all possible side effects. The mechanism of action of cagrilintide is most clearly linked to these phenomena. The most common negative reactions were short-lived, mainly mild or moderate stomach problems, usually happening when the dose was increased.

Satifam® should not be used by patients with a family or personal history of medullary thyroid cancer or type 2 multiple endocrine neoplasia syndrome, who are very sensitive to cagrilintide or any of the ingredients of the drug, who have problems with their intestines or often have heartburn.

Be sure to consult your doctor before using this medicine, as they will be able to advise you on the appropriate course of action.

What is the correct way to take Cagrilintide 20 mg using a pen injector?

To minimise side effects, it is recommended that the dosage is increased gradually:

• The lowest possible starting dose for both standalone and combined use of cagrilintid is 1 mg, which should be administered subcutaneously once a week.

• From the second week onwards, the dose can be doubled to 2 mg, provided the medication is tolerated well.

• Should you wish to attain greater appetite control, the weekly dosage may be augmented by 1 mg on a weekly basis. If more than 4 mg is required, several injections can be given in different areas, at least 5 cm apart.

• The most you can take each week is 6 mg.

• In the event of an inadvertent omission, Satifam® should be administered at the earliest opportunity, no later than five days (120 hours) from the scheduled time. In the event that a period of five days has elapsed, the subsequent injection should be administered on the customary day in accordance with the stipulated schedule. After that, you can return to the usual once-weekly regimen.

• In the event that this proves necessary, the day of weekly administration may be subject to alteration. In this case, ensure there is at least a 4-day (96-hour) interval between two doses.

• In the event of concomitant administration of Cagrilintide and insulin, it is imperative that both substances are administered separately and in no instance should they be mixed. You may only need to adjust your insulin dose if you reduce the amount of food you consume.

Satifam® is administered once a week. It can be taken at any time of day. It does not matter whether food is eaten. It is recommended that injections are given under the skin in the stomach area, the upper leg or the shoulder. And just remember, you've got to change the injection site each time.

The store manager will be available for the answering of any questions. Right now, you can order the 20 mg Cagriltide pen injector from our website and have it delivered to your address. We can send our products worldwide.

Pay close attention! Before sports nutrition is taken, the doctor should be consulted and the list of contraindications for the product should be read. The manufacturer may change the appearance of the packaging without notice.